Samuel Kintz
Oprichter bij ENLIVEN THERAPEUTICS, INC.
Vermogen: 21 M $ op 30-04-2024
Profiel
Samuel S.
Kintz is the founder of Enliven Therapeutics, Inc. (founded in 2019) and currently holds the titles of President, Chief Executive Officer & Director.
Mr. Kintz's education history includes an undergraduate degree from Stanford University and an MBA from Stanford Graduate School of Business.
Mr. Kintz is also the founder of Enliven Therapeutics, Inc...
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-04-2024 | 1 264 587 ( 2.70% ) | 21 M $ | 30-04-2024 |
Actieve functies van Samuel Kintz
| Bedrijven | Functie | Begin |
|---|---|---|
| ENLIVEN THERAPEUTICS, INC. | Oprichter | 01-06-2019 |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Oprichter | - |
Opleiding van Samuel Kintz
| Stanford University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENLIVEN THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Health Technology |
